Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korio is a private health technology company that develops interactive response technology and randomization and trial supply management software for clinical trials. The company focuses on helping life sciences sponsors, CROs, and study teams manage patient randomization, enrollment, investigational product supply, and mid-study protocol changes through a compliance-centric RTSM platform. Korio positions itself as a specialist vendor dedicated exclusively to RTSM, with emphasis on flexibility, automated testing, reusable configurations, auditability, and support for complex global studies. Its offerings also include advisory services for protocol and RTSM design as well as validated mid-study migration tools for sponsors switching vendors during active trials. The company serves the clinical development ecosystem rather than developing therapeutic products of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korio.